Quarterly Activity Chart
Adds vs. Reduces by Quarter
PaperPanda Equity Terminal
ELVN —
ENLIVEN THERAPEUTICS INC
CUSIP: 29337E102 · Held by 1 superinvestor · Combined value: $22,207,477
Latest News
Loading financials…
| # | Investor | % of Portfolio | Value ($) | Shares | Recent Activity | Share Change |
|---|---|---|---|---|---|---|
| 1 | Ken Griffin | 0.0% | $22,207,477 | 1,442,044 | ADD | +281,541 |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Ken Griffin | ADD | +281,541 | +24.3% |
| Jim Simons | SOLD | -59,000 | Exit |
| Stanley Druckenmiller | SOLD | -947,405 | Exit |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Jim Simons | ADD | +35,100 | +146.9% |
| Stanley Druckenmiller | ADD | +484,405 | +104.6% |
| Ken Griffin | REDUCE | -309,921 | -21.1% |
Who Owns ELVN? Superinvestor Holdings
ENLIVEN THERAPEUTICS INC is held by 1 tracked superinvestor, with a combined position value of $22 million . The largest positions are held by Ken Griffin (0.0% of portfolio).
In the most recent quarter, 1 superinvestor added or initiated positions.